Listas Anotadas de Medicamentos e Dispositivos
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Outras observações: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
| PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Outras observações: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Outras observações: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
| PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Outras observações: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Outras observações: Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives. |
| PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Outras observações: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |